2020B14 Briefly outline the potential immunological effects of transfusing packed red cells.

 

Immediate:

Febrile non-haemolytic

·     Donor blood storage -> cytokine accumulation (IL-1, IL-6, TNF-α)

·     Fever, malaise, dyspnoea

·     Not harmful

Febrile haemolytic

·     Due to incompatible transfusion

·     RBC > platelets > FFP

·     (Normal) prior alloimmunisation due to molecular mimicry by gut flora

·     Donor antigen vs recipient antibody

·     ABO IgM-> intravascular haemolysis (DIC, renal failure, death)

·     RhD IgG-> extravascular haemolysis (haemolytic anaemia)

Anaphylaxis

·     Type 1 hypersensitivity

·     FFP and platelets > RBC

·     Donor protein vs recipient IgE

·     Especially IgA vs IgA-deficient host

·     Mast cell degranulation -> vasodilation, bronchospasm, angioedema

TRALI

·     Transfusion-related acute lung injury

·     FFP and platelets > RBC

·     ? Donor antibody vs recipient lung antigen

·     ? Illness-related priming of neutrophils and endothelium

·     Non-cardiogenic pulmonary oedema

·     Major cause of mortality

·     FFP and platelets > others

·     Onset during transfusion or < 6 hours

 

Delayed:

Alloimmunisation

·     First exposure to antigen during transfusion or childbirth

·     Alloantibodies produced

·     Second exposure results in antibody-mediated destruction

Delayed haemolytic reaction:

·     Especially if recurrent transfusion

·     Antibodies: Kell, Kidd, Duffy

·     Diminishing antibody titre -> re-exposure -> anamnestic response

·     Extravascular haemolysis -> haemolytic anaemia

Haemolytic disease of the newborn:

·     RhD+ foetus vs RhD- mother; or Kell(+) foetus vs Kell(-) mother

·     IgG crosses placenta -> severe haemolysis

·     Prevented by anti-D at 28/40 and 34/40 in RhD- women

Post-transfusion purpura:

·     Donor platelet vs recipient alloantibodies

·     Consumption of both donor platelets and bystanders

Immunomodulation

·     Mechanism unclear - ? donor WBC or mediators

·     ↑Post-op infection, ↑cancer recurrence

·     Rationale for cell salvage use in major cancer surgery

Graft vs host

·     Donor WBC multiplies in immunocompromised host -> tissue damage

·     Affects skin (rash), marrow (suppression), liver (↑LFT), GIT (diarrhoea)

·     Rare, fatal, untreatable

·     Prevented by gamma irradiation of blood product

 

 

Feedback welcome at ketaminenightmares@gmail.com